Current Opinion in Infectious Diseases

Article	Citations
Potential opportunities and challenges for infection prevention and control for cystic fibrosis in the modern era	88
Editorial introductions	39
Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV	37
Strongyloidiasis-related lung involvement: too much of a bad thing	37
From diagnosis to management: current perspectives on congenital cytomegalovirus infection	35
Postexposure prophylaxis for occupational exposure to selected pathogens for healthcare personnel	31
Infection prevention measures in acute care settings based on severe acute respiratory syndrome coronavirus 2 transmission patterns and risk: a review	30
Surgical management of cystic echinococcosis of the liver	30
Complexities of cardiomyopathy in septic shock	29
Corticosteroids for viral central nervous system infections	29
Skin and soft tissue infections in the elderly	28
La Crosse virus encephalitis in children	28
Epstein–Barr virus posttransplant lymphoproliferative disorder: update on management and outcomes	27
Invasive aspergillosis in coronavirus disease 2019: a practical approach for clinicians	27
Long and persistent COVID-19 in patients with hematologic malignancies: from bench to bedside	26
Babesiosis in immunosuppressed hosts: pathogenesis, diagnosis and management	25
Immunocompromised host section: Adoptive T-cell therapy for dsDNA viruses in allogeneic hematopoietic cell transplant recipients	24
Bacterial cholesterol-dependent cytolysins and their interaction with the human immune response	24
Typhoid fever control in the 21st century: where are we now?	24
Fusarium species central nervous system infection	23
Methicillin-resistant Staphylococcus aureus lung infection in coronavirus disease 2019: how common?	23
Progress and challenges in human papillomavirus and cervical cancer in southern Africa	23
New therapies for nontuberculous mycobacterial lung infection	23
Resistant herpes simplex virus infections – who, when, and what's new?	20
Viral meningitis and encephalitis: an update	20

Malaria in pregnancy: baby steps	20
Mycobacterial skin infection	20
Tuberculosis molecular bacterial load assay in the management of tuberculosis	20
Mpox in people living with HIV	20
Duration of antibiotic therapy in central venous catheter-related bloodstream infection due to Gram-negative bacilli	19
Follow-up blood culture in Gram-negative bacilli bacteraemia: for whom is follow-up blood culture useful?	19
The reemergence of Streptococcus pyogenes in skin and soft tissue infections: a review of epidemiology, pathogenesis, and management strategies	19
Tick-borne encephalitis	19
Mitigation of nontuberculous mycobacteria in hospital water: challenges for infection prevention	19
Diagnostic stewardship: what impacts antibiotics use?	18
Using antibiotics wisely	18
Multidrug-resistant, gram-negative infections in high-risk haematologic patients: an update on epidemiology, diagnosis and treatment	18
Gut microbiome and its clinical implications: exploring the key players in human health	17
Editorial introductions	17
How coronavirus disease will change the face of travel medicine	17
New diagnostic strategies to distinguish Crohn's disease and gastrointestinal tuberculosis	17
Does climate change threaten delivery of HIV care in resource-limited settings?	16
Diagnostic approach and update on encephalitis	16
CMV antiviral stewardship in transplantation – the next frontier	16
Global health security as it pertains to Zika, Ebola, and COVID-19	16
The impact of coronavirus disease 2019 on people with HIV	15
Beyond antivirals: virus-specific T-cell immunotherapy for BK virus haemorrhagic cystitis and JC virus progressive multifocal leukoencephalopathy	15
How to differentiate skin rash in covid, mononucleosis, chickenpox, sixth disease and measles	15
Risk stratification for selecting empiric antibiotherapy during and after COVID-19	15
Emerging treatment options for cryptosporidiosis	15
Prevention strategies for congenital cytomegalovirus infection	15
Appropriate surgical management in skin and soft tissue infections	15
Update on the treatment of chronic pulmonary aspergillosis	14
The microbiota in respiratory tract infections: from association to intervention	14
Immunotherapeutic approaches to HIV cure and remission	13
Respiratory syncytial virus in children: epidemiology and clinical impact post-COVID-19	13
Prenatal and postnatal antiviral therapies for the prevention and treatment of congenital cytomegalovirus infections	13
Drivers of melioidosis endemicity: epidemiological transition, zoonosis, and climate change	13
Large lessons learned from small vessels: coronary microvascular dysfunction in HIV	13
Artemisinin and multidrug-resistant Plasmodium falciparum – a threat for malaria control and elimination	13
Editorial: Pathogenesis and immune response – editorial	12
New trends in congenital syphilis: epidemiology, testing in pregnancy, and management	12
Childhood tuberculosis	12
Human adenovirus lung disease: outbreaks, models of immune-response-driven acute lung injury and pandemic potential	12
Editorial introductions	12
Interpreting and managing preservation fluids positive for Gram-negative bacteria	12
The role of macrolides in severe community-acquired pneumonia and the potential impact of macrolide-resistant Mycoplamsa pneumoniae	12
An overview of risk factors, management and prevention of cochlear implant infections	11
Emerging treatment options for skin and soft tissue infections tailoring drug selection to individual patients	11
Update on drug treatments for multidrug resistant tuberculosis	11
H5 and H9 avian influenza – potential re-emergent zoonotic threats to humans	11
Respiratory metagenomics: route to routine service	11
Short treatment duration for community-acquired pneumonia	11
The disease burden of respiratory syncytial virus in Infants	10
The microbiome as a biomarker of anal precancerous lesions in people with HIV	10

Emerging infections in vulnerable hosts: Stenotrophomonas maltophilia and Elizabethkingia anophelis	10
Alveolar echinococcosis: what triggers emergence in North America, Central Europe and Asia?	10
Antibiotic therapy for nonfermenting Gram-negative bacilli infections: future perspectives	10
Identifying patients with difficult-to-treat acute bacterial skin infections	10
Neurobrucellosis	9
Short-course antibiotic strategies for ventilator-associated pneumonia	9
A new era of HIV care for age-associated multimorbidity	9
Skin and soft tissue infections in solid organ transplants	9
Burden of influenza in the elderly: a narrative review	9
Novel techniques in the treatment of skin and soft tissue infection	9
The role of Gram-negative bacteria in skin and soft tissue infections	9
Pneumocystis jirovecii in solid organ transplant recipients: updates in epidemiology, diagnosis, treatment, and prevention	9
Staphylococcus aureus infections in children	8
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity	8
Editorial introductions	8
New evidence for managing Gram-negative bloodstream infections	8
Duration of antibiotic therapy in Gram-negative infections with a particular focus on multidrug-resistant pathogens	8
Effective strategies for managing trimethoprim-sulfamethoxazole and levofloxacin-resistant Stenotrophomonas maltophilia infections: bridging the gap between scientific evidence and clinical practice	8
Editorial introductions	8
Updates on the neurological manifestations of SARS-CoV-2 infection	8
The evolution of knowledge for treating Gram-negative bacterial infections	8
The role of older antibiotics in the treatment of skin and soft tissue infections: current perspectives	8
Editorial introductions	8
Endemic viral infections in immunocompromised hosts: Dengue, Chikungunya, Zika	8
Policy and planning for large epidemics and pandemics – challenges and lessons learned from COVID-19	8
Zoonoses and global epidemics	8
Therapeutic agents for the treatment of human mpox	8
Antibiotic treatment of acute bacterial skin and skin structure infections	8
Chagas disease in the immunocompromised host	8
Immune responses and severe dengue: what have we learned?	8
Dose optimisation of antibiotics used for meningitis	8
Surgical site infection prophylaxis: what have we learned and are we making progress?	8
Mycetoma, chromoblastomycosis and other deep fungal infections: diagnostic and treatment approach	8
Antiviral therapies for influenza	7
Antifungal hypersensitivity reactions and cross-reactivity patterns	7
Editorial introductions	7
The implications of the COVID-19 pandemic for long term care facilities	7
Medical management of cystic echinococcosis	7
Novel strategies for prevention and treatment of antimicrobial resistance in sexually-transmitted infections	7
Community-acquired skin and soft-tissue infections in people who inject drugs	7
Shifting the power: scale-up of access to point-of-care and self-testing for sexually transmitted infections in low-income and middle-income settings	7
Editorial introductions	7
When is it a sexually transmitted infection? Intimate contact transmission of pathogens not traditionally defined as STIs	7
Universal versus targeted treatment of neonatal herpes simplex virus among neonates presenting for sepsis evaluations	7
Preventing respiratory viral transmission in healthcare settings	7
Editorial introductions	7
Choosing antibiotic therapy for severe community-acquired pneumonia	7
The future of Clostridioides difficile diagnostics	7
Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections	7
Editorial introductions	7
Management of nonfermenting gram-negative infections: a critique of the guidelines	7
Cytomegalovirus in primary immunodeficiency	7
Editorial: Friends and foes: “The quarrels of friends are the opportunities of foes”	7
Editorial introductions	6
Risk factors for cognitive decline in persons with HIV	6
Bacteriophages against enteropathogens: rediscovery and refinement of novel antimicrobial therapeutics	6
Endemic parasitic infections in donors and recipients of stem cell and solid organ transplants: focus on strongyloidiasis and Chagas disease	6
Biomarkers to predict cardiovascular disease in people living with HIV	6
Risk factors for severity in seasonal respiratory viral infections and how they guide management in hematopoietic cell transplant recipients	6
Giardia and growth impairment in children in high-prevalence settings: consequence or co-incidence?	6
Current international and national guidelines for managing skin and soft tissue infections	6
Climate change and resilience for antimicrobial stewardship and infection prevention	6
How to use new antibiotics in the therapy of ventilator-associated pneumonia	6
Empirical antibiotic therapy for difficult-to-treat Gram-negative infections: when, how, and how long?	6
The power of story: what Victorian novels can teach us about public health	6
Horizontal versus vertical strategies for infection prevention: current practices and controversies	6
Vaccine hesitancy and other challenges to sexually transmitted infection vaccine acceptance	5
Strongyloides stercoralis infection in solid organ transplant recipients	5
Antiviral combination treatment strategies for SARS-CoV-2 infection in immunocompromised patients	5
The microbiology and pathogenesis of nonfermenting Gram-negative infections	5
Editorial introductions	5
Central nervous system infections in the tropics	5
Current challenges in neurocysticercosis: recent data and where we are heading	5
Brain abscess in immunocompetent patients: recent findings	5
What will it take to meet UNAIDS targets for preexposure prophylaxis users?	5
Adjuvanted recombinant zoster vaccine in solid organ transplant and hematopoietic stem-cell transplant recipients	5
Viral diarrheas – newer advances in diagnosis and management	5
Viral infections and inborn errors of immunity	5
Editorial introductions	5
Neutropenia and antibiotics: when, what, how and why?	4

Advances and challenges in sexually transmitted infections prevention among men who have sex with men in Asia	4
Skin and soft tissue infections due to rapidly growing mycobacteria	4
Antimicrobial-resistant bacteria in international travelers	4
Mpox exposure and transmission in healthcare settings during the 2022 global outbreak	4
The role of the genital microbiota in the acquisition and pathogenesis of sexually transmitted infections	4
New antibiotics in clinical pipeline for treating infections caused by metallo-β-lactamases producing Gram-negative bacteria	4
A work in progress: antimicrobial stewardship in solid organ transplant patient populations	4
Escherichia coli 0157:H7 virulence factors and the ruminant reservoir	4
Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention	4
‘No cyst, no echinococcosis’: a scoping review update on the diagnosis of cystic echinococcosis after the issue of the WHO-IWGE Expert Consensus and current perspectives	4
Editorial introductions	4
How to treat severe Acinetobacter baumannii infections	4
Gastrointestinal involvement in post-acute Coronavirus disease (COVID)-19 syndrome	4
Respiratory viral infections in children with cancer and febrile neutropenia and children undergoing hematopoietic stem cell transplantation	4
Infant feeding: emerging concepts to prevent HIV transmission	4
The present and future of blood virome in allogeneic hematopoietic cell transplant recipients	4
The role of sulbactam-durlobactam in treating carbapenem-resistant Acinetobacter infections	4
Nontyphoidal Salmonella infections acquired from poultry	4
Impact of respiratory viral infections on nasopharyngeal pneumococcal colonization dynamics in children	4
Infectious mononucleosis: new concepts in clinical presentation, epidemiology, and host response	4
Parental vaccine hesitancy: scope, causes, and potential responses	4
NSAIDs for early management of acute respiratory infections	4
Update on cytomegalovirus in transplant recipients: new agents, prophylaxis, and cell-mediated immunity	4